找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Ovarian Cancer; State of the Art and George Coukos,Andrew Berchuck,Robert Ozols Conference proceedings 2008 The Editor(s) (if applicable) a

[復(fù)制鏈接]
樓主: tornado
51#
發(fā)表于 2025-3-30 11:41:05 | 只看該作者
52#
發(fā)表于 2025-3-30 14:40:39 | 只看該作者
Potential and Limitations in Early Diagnosis of Ovarian Cancerhe last decade (2, 3). However, using these markers to detect ovarian cancer early enough to reduce mortality remains challenging because screening needs to identify cancer before symptoms occur, early enough that the disease is still curable. It is well established that the best screening tests det
53#
發(fā)表于 2025-3-30 19:56:22 | 只看該作者
54#
發(fā)表于 2025-3-30 21:05:02 | 只看該作者
Classification of Ovarian Cancer: A Genomic Analysishese histotypes resemble various müllerian cell types, with serous tumors resembling Fallopian tube, endometrioid tumors resembling uterine endometrium, mucinous tumors resembling the endocervix, and clear cell tumors resembling endometrial glands during pregnancy (2). Tumors are graded from 1 to 3,
55#
發(fā)表于 2025-3-31 03:02:31 | 只看該作者
56#
發(fā)表于 2025-3-31 07:13:26 | 只看該作者
57#
發(fā)表于 2025-3-31 12:17:34 | 只看該作者
58#
發(fā)表于 2025-3-31 13:47:13 | 只看該作者
59#
發(fā)表于 2025-3-31 18:06:03 | 只看該作者
Intraperitoneal Chemotherapy for Ovarian Cancerhe peritoneal cavity for much of its natural history, this approach seemed rational. Despite encouraging early results, the IP approach has not been incorporated into the mainstream management of advanced ovarian cancer.
60#
發(fā)表于 2025-3-31 23:25:00 | 只看該作者
Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer the mechanisms that underlie chemoresistance is central to improving patient outcomes for ovarian cancer..The standard adjuvant therapy for ovarian cancer at this time is combination chemotherapy with a platinum-based drug and paclitaxel. The underlying principle of cancer therapy is the selective
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-18 21:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
枣强县| 新竹市| 团风县| 若羌县| 太原市| 合阳县| 张家界市| 上饶县| 万年县| 行唐县| 海丰县| 太康县| 灵丘县| 靖西县| 郑州市| 建昌县| 醴陵市| 稷山县| 百色市| 绥芬河市| 体育| 绥化市| 南召县| 通渭县| 贵德县| 萍乡市| 阜康市| 锡林浩特市| 中西区| 卢龙县| 平顶山市| 泸水县| 怀仁县| 临泉县| 耒阳市| 阳江市| 鄂州市| 晋宁县| 永平县| 奎屯市| 陆良县|